Hyperthermia enhances the effect of β-lapachone to cause γH2AX formations and cell death in human osteosarcoma cells
/in Hyperthermia, International Publications /von 2010-11-11 / Int J Hyperthermia 2011;27(1):53-62NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment
/in Hyperthermia, International Publications /von 2010-11-08 / Proc. Natl. Acad. Sci. U.S.A. 2010 Nov;107(47):20477-82Combination of ionising irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells
/in Colorectal Cancer, Hyperthermia, International Publications /von 2010-11-08 / Strahlenther Onkol 2010 Nov;186(11):587-99[Multidisciplinary therapy for 984 cancer patients–hyperthermic immunotherapy]
/in Hyperthermia, International Publications /von 2010-11-01 / Gan To Kagaku Ryoho 2010 Nov;37(12):2243-5Palliation of recurrent myxofibrosarcoma with radiotherapy and hyperthermia
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2010-11-01 / Singapore Med J 2010 Nov;51(11):e187-90The role of hyperthermia in the battle against cancer
/in Hyperthermia, International Publications /von 2010-11-01 / Tumori 2010 Nov-Dec;96(6):902-10Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94-153
/in Hyperthermia, International Publications, Prostate Cancer /von 2010-09-30 / Cancer 2011 Feb;117(3):510-6Intracavity hyperthermia in nasopharyngeal cancer: a phase III clinical study
/in Hyperthermia, International Publications /von 2010-09-21 / Int J Hyperthermia 2011;27(2):180-6Measurement and mathematical modeling of thermally induced injury and heat shock protein expression kinetics in normal and cancerous prostate cells
/in Hyperthermia, International Publications, Prostate Cancer /von 2010-09-21 / Int J Hyperthermia 2010;26(8):748-64
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de